Breast cancer cases with positive PR status had 6.19-fold CNTN-1 mRNA expression while PR negative breast cancer cases had 4.44-fold CNTN-1 mRNA expression (p=0.03). This evidence concerns the gene CNTN1 and breast carcinoma.